Showing results (21-30 of 99) with videos related to
Sort By:
Pageof 10
Journal of the Chinese Medical Association : JCMA|December 5, 2019
Clusterin expression in nontumor tissue in patients with resectable hepatocellular carcinoma related with postresectional survivalPo-Chung Kuo, Ivy Yenwen Chau, Anna Fen-Yau Li, et al.FEBS Letters|February 5, 2008
Peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1alpha) upregulated E-cadherin expression in HepG2 cellsHui-Ju Lee, Yeu Su, Wing-Yiu Lui, et al.Plos One|January 13, 2022
Postoperative fever after liver resection: Incidence, risk factors, and characteristics associated with febrile infectious complicationHon-Fan Lai, Ivy Yenwen Chau, Hao-Jan Lei, et al.Journal of the American College of Surgeons|September 27, 2006
Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinomaHao-Jan Lei, Gar-Yang Chau, Wing-Yiu Lui, et al.International Journal of Cancer|June 11, 2013
Serum interferon gamma level predicts recurrence in hepatocellular carcinoma patients after curative treatmentsI-Cheng Lee, Yi-Hsiang Huang, Gar-Yang Chau, et al.BMC Genomics|October 29, 2013
Forfeited hepatogenesis program and increased embryonic stem cell traits in young hepatocellular carcinoma (HCC) comparing to elderly HCCHsei-Wei Wang, Tsung-Han Hsieh, Ssu-Yi Huang, et al.Journal of the Chinese Medical Association : JCMA|February 11, 2004
Risk factors associated with intra-operative major blood loss in patients with hepatocellular carcinoma who underwent hepatic resectionChao-Hsu Li, Gar-Yang Chau, Wing Yiu Lui, et al.European Journal of Gastroenterology & Hepatology|September 24, 2011
Radiofrequency ablation for recurrent hepatocellular carcinoma in postresectional patients: prognostic factors analysisYen-Huai Lin, Yi-You Chiou, Yi-Hong Chou, et al.American Journal of Surgery|January 31, 2006
Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: a multicenter, randomized, double-blind, placebo-controlled trialYong-Fu Shao, Jia-Mei Yang, Gar-Yang Chau, et al.Cancer Letters|September 3, 2004
Polymorphisms of estrogen-metabolizing genes and risk of hepatocellular carcinoma in Taiwan femalesPen-Hui Yin, Hsin-Chen Lee, Gar-Yang Chau, et al.Pageof 10